Pharmacological Interventions for Opioid-Induced Hyperalgesia: A Scoping Review of Preclinical Trials
- PMID: 36498635
- PMCID: PMC9735807
- DOI: 10.3390/jcm11237060
Pharmacological Interventions for Opioid-Induced Hyperalgesia: A Scoping Review of Preclinical Trials
Abstract
Background: Opioid analgesics are the most effective pharmacological agents for moderate and severe pain. However, opioid use has several limitations such as opioid-induced hyperalgesia (OIH), which refers to the increased pain sensitivity that occurs once analgesia wears off after opioid administration. Several pharmacological interventions have been suggested for OIH, but the current literature does not provide guidelines on which interventions are the most effective and whether they differ depending on the opioid that induces hyperalgesia. This scoping review aimed to identify and describe all the preclinical trials investigating pharmacological interventions for OIH caused by remifentanil, fentanyl, or morphine as the first step towards evaluating whether the most effective OIH interventions are different for different opioids.
Methods: Electronic database searches were carried out in Embase, PubMed, and Web of Science. Detailed data extraction was conducted on the eligible trials.
Results: 72 trials were eligible for the review. Of these, 27 trials investigated remifentanil, 14 trials investigated fentanyl, and 31 trials investigated morphine. A total of 82 interventions were identified. The most studied interventions were ketamine (eight trials) and gabapentin (four trials). The majority of the interventions were studied in only one trial. The most common mechanism suggested for the interventions was inhibition of N-methyl-D-aspartate (NMDA) receptors.
Conclusion: This scoping review identified plenty of preclinical trials investigating pharmacological interventions for OIH. Using the current literature, it is not possible to directly compare the effectiveness of the interventions. Hence, to identify the most effective interventions for each opioid, the interventions must be indirectly compared in a meta-analysis.
Keywords: fentanyl; morphine; opioid-induced hyperalgesia; pain; remifentanil.
Conflict of interest statement
P.F. received speaker fees from Grunenthal for an educational activity not related to any product. No other competing interests to declare.
Figures
Similar articles
-
Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.Health Technol Assess. 2022 Oct;26(44):1-310. doi: 10.3310/ZUCE8371. Health Technol Assess. 2022. PMID: 36321689 Free PMC article.
-
Exploring conceptual and theoretical frameworks for nurse practitioner education: a scoping review protocol.JBI Database System Rev Implement Rep. 2015 Oct;13(10):146-55. doi: 10.11124/jbisrir-2015-2150. JBI Database System Rev Implement Rep. 2015. PMID: 26571290
-
Ethics of Procuring and Using Organs or Tissue from Infants and Newborns for Transplantation, Research, or Commercial Purposes: Protocol for a Bioethics Scoping Review.Wellcome Open Res. 2024 Dec 5;9:717. doi: 10.12688/wellcomeopenres.23235.1. eCollection 2024. Wellcome Open Res. 2024. PMID: 39839977 Free PMC article.
-
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3. Syst Rev. 2024. PMID: 39593159 Free PMC article.
-
Oxycodone for cancer-related pain.Cochrane Database Syst Rev. 2022 Jun 9;6(6):CD003870. doi: 10.1002/14651858.CD003870.pub7. Cochrane Database Syst Rev. 2022. PMID: 35679121 Free PMC article. Review.
Cited by
-
Continuous ketamine infusion for the management of opioid-induced hyperalgesia following amputation.BMJ Case Rep. 2024 Jan 4;17(1):e255333. doi: 10.1136/bcr-2023-255333. BMJ Case Rep. 2024. PMID: 38176753
-
Cold nociception as a measure of hyperalgesia during spontaneous heroin withdrawal in mice.Pharmacol Biochem Behav. 2024 Feb;235:173694. doi: 10.1016/j.pbb.2023.173694. Epub 2023 Dec 20. Pharmacol Biochem Behav. 2024. PMID: 38128767 Free PMC article.
-
Developmental outcomes with perinatal exposure (DOPE) to prescription opioids.NeuroImmune Pharm Ther. 2023 Nov 27;2(4):339-351. doi: 10.1515/nipt-2023-0017. eCollection 2023 Dec. NeuroImmune Pharm Ther. 2023. PMID: 38058996 Free PMC article. Review.
-
Impact of Prescription Opioid Detoxification on Quality of Life and Pain Levels.Clin Pract. 2024 Aug 8;14(4):1529-1537. doi: 10.3390/clinpract14040123. Clin Pract. 2024. PMID: 39194927 Free PMC article.
-
Chronic Visceral Pain: New Peripheral Mechanistic Insights and Resulting Treatments.Gastroenterology. 2024 Jun;166(6):976-994. doi: 10.1053/j.gastro.2024.01.045. Epub 2024 Feb 5. Gastroenterology. 2024. PMID: 38325759 Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources